Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia C McKean

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the hospitalized medical patientAmir K Jaffer, Alpesh N Amin, Daniel J Brotman, et al.
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the cancer surgery patientAlex C Spyropoulos, Daniel J Brotman, Alpesh N Amin, et al.
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the orthopedic surgery patientSteven B Deitelzweig, Sylvia C McKean, Alpesh N Amin, et al.
The American Journal of Cardiology|August 9, 2006
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolismRene Quiroz, Marie Gerhard-Herman, Joshua M Kosowsky, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 17, 2009
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control studyMelkon Hacobian, Ranjith Shetty, Clyde Matthew Niles, et al.
Archives of Internal Medicine|March 15, 2006
Role of pharmacist counseling in preventing adverse drug events after hospitalizationJeffrey L Schnipper, Jennifer L Kirwin, Michael C Cotugno, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the hospitalized medical patientAmir K Jaffer, Alpesh N Amin, Daniel J Brotman, et al.
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the cancer surgery patientAlex C Spyropoulos, Daniel J Brotman, Alpesh N Amin, et al.
Cleveland Clinic Journal of Medicine|May 23, 2008
Prevention of venous thromboembolism in the orthopedic surgery patientSteven B Deitelzweig, Sylvia C McKean, Alpesh N Amin, et al.
The American Journal of Cardiology|August 9, 2006
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolismRene Quiroz, Marie Gerhard-Herman, Joshua M Kosowsky, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 17, 2009
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control studyMelkon Hacobian, Ranjith Shetty, Clyde Matthew Niles, et al.
Archives of Internal Medicine|March 15, 2006
Role of pharmacist counseling in preventing adverse drug events after hospitalizationJeffrey L Schnipper, Jennifer L Kirwin, Michael C Cotugno, et al.
Pageof 1